Vivani Medical is trading at $1.34, 7.20% up, on September 11, 2026, amid firmer pre-market indices and broader risk-on sentiment.
- A pre-recorded H.C. Wainwright company presentation became available at 7:00 a.m. Eastern Time on September 11, following the companyβs September 3 announcement.
- No clear new earnings, financing, regulatory, or clinical announcement was identified.
- The move aligns with broader risk-on sentiment rather than a confirmed company-specific catalyst.